Scientific Terms
Invitae Publishes First Validation Data on MRD Assays, Laying Path to Future Clinical Expansion
Premium
The analytical validity study is the first published featuring full performance data for the firm's Personalized Cancer Monitoring technology.
Tasso Gets CE Mark for Blood Collection Device
The device, which allows for the self-collection of microliter capillary whole blood samples, was recently cleared by the US Food and Drug Administration.
Myriad Genetics, Memorial Sloan Kettering Partner to Study MRD Testing in Breast Cancer
The collaborators will evaluate the use of Myriad's MRD platform in predicting response to CDK4/6 inhibitors and in a chemotherapy neoadjuvant setting.
I-SPY 2 Trial to Evaluate Natera's Signatera for Post-Neoadjuvant Breast Cancer Monitoring
Researchers will evaluate the MRD test's ability to monitor neoadjuvant treatment response in 600 breast cancer patients in real time.
Scotland's Microplate Dx Secures £2.5M Seed Funding
The firm plans to use the funding to advance clinical trials for urinary tract infection antimicrobial susceptibility testing.